OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
5.19
-0.33 (-5.98%)
Dec 3, 2024, 2:06 PM EST - Market open
OptimizeRx Employees
As of December 31, 2023, OptimizeRx had 136 total employees, including 135 full-time and 1 part-time employees. The number of employees increased by 26 or 23.64% compared to the previous year.
Employees
136
Change (1Y)
26
Growth (1Y)
23.64%
Revenue / Employee
$648,379
Profits / Employee
-$177,749
Market Cap
95.60M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Harvard Bioscience | 416 |
Veru Inc. | 189 |
Adagene | 174 |
Generation Bio Co. | 174 |
Vigil Neuroscience | 69 |
Avalo Therapeutics | 19 |
MediciNova | 13 |
Nuvectis Pharma | 13 |
OPRX News
- 15 days ago - OptimizeRx to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 19 days ago - OptimizeRx Corporation (OPRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET - GlobeNewsWire
- 3 months ago - OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value - GlobeNewsWire
- 3 months ago - OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences - GlobeNewsWire
- 4 months ago - OptimizeRx Corporation (OPRX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET - GlobeNewsWire
- 4 months ago - OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation - GlobeNewsWire